source · text/markdown
source_8d7de3d53aaf4c9c
sha256 3eaa05dd408d7a2cac8ca4360d7ed87b5b1d8a3cce89f1f30f6a780adc27c5ff
by researka:v2 · 2026-06-28 18:41:02.447638+04:00
# Alpha memo: resveratrol / exercise bounded update **Research question:** Does the positive signal in Receipt 1 hold in the setting tested by Receipt 2? **One-sentence alpha:** resveratrol / exercise looks positive in Receipt 1 but is limited by Receipt 2, so the alpha is an endpoint- and setting-dependent update rather than a universal benefit claim. **Receipt 1:** Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats | 2012 | 10.1113/jphysiol.2012.230490 **Receipt 2:** Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men | 2014 | 10.1113/jphysiol.2013.270256 **Synthesis:** Receipt 1 reports Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats in an animal model. Receipt 2 reports Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men in a human study. The comparison is bounded to resveratrol / exercise, and should not be read as advice, settled science, or a broad class claim. **Why this is surprising:** The same named anchor is not enough. The useful signal is the boundary between the two receipt settings and endpoints, not a literature-average claim about resveratrol / exercise. **Caveats/falsifiers:** - A head-to-head study with the same population, dose, duration, and endpoint would outrank this pair. - Species, endpoint class, dose, duration, or modality differences could explain the split. - If Receipt 2 measured a different endpoint, treat the memo as a boundary signal rather than a failure claim. - If a later human or field trial reproduces Receipt 1 on the same endpoint, reject the update. **Next test:** Run the same resveratrol / exercise comparison in one matched design before treating the signal as general.
metadata
{
"article_type": "alpha_memo",
"domain_slug": "longevity_research",
"researka_object_type": "submission",
"researka_submission_id": "843d2284-e249-4ab6-abb1-e31531c276f3",
"title": "Alpha memo: resveratrol / exercise bounded update"
}